JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT

  • 0Fels Cancer Institute for Personalized Medicine.
Research Square +

|

May 20, 2024

|

May 20, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Researchers developed a new method to create normal prostate epithelial cell (PrEC) lines for studying prostate cancer (PCa). This technique uses minimal genetic changes, generating valuable tools for PCa research and addressing a critical shortage of cell lines.

Area Of Science

  • Cell Biology
  • Cancer Research
  • Genetics

Background

  • Prostate cancer (PCa) is a prevalent cancer globally, with significant mortality and racial disparities.
  • A limited number of normal and cancer cell lines hinders research into PCa progression.
  • Karyotypically normal prostate epithelial cell (PrEC) lines are crucial for understanding PCa molecular mechanisms.

Approach

  • Developed a novel, one-step methodology for rapid immortalization of normal human PrEC.
  • Combined CRISPR-directed inactivation of CDKN2A exon 2 (p16INK4A/p14ARF) with hTERT transgene expression.
  • Optimized the approach by targeting CDKN2A exon 1α for selective p16INK4A ablation, preserving p14ARF.

Key Points

  • Established two new cell lines: one with p16INK4A loss only, and another with dual p16INK4A/p14ARF loss.
  • Characterized cell line lineage, revealing distinct gene expression signatures related to basal prostatic cells.
  • The methodology employs minimal genetic alterations essential for immortalization.

Conclusions

  • The developed cell lines serve as valuable models for prostate cancer research.
  • This efficient immortalization technique is suitable for generating cell lines from primary prostate tumors.
  • Addresses the urgent need for more prostate cancer cell lines to advance research.